CARDIFF ONCOLOGY, INC.: 10-Q filed 2012-05-15

Name: CARDIFF ONCOLOGY, INC.: 10-Q filed 2012-05-15
Creator: CARDIFF ONCOLOGY, INC.

What CARDIFF ONCOLOGY, INC. reported in its quarterly report filed 2012-05-15 (fiscal Q1 2012): 28 published measures, 91 facts as tagged in accession 0001104659-12-037472.

This filing

Form: 10-Q (quarterly report)
Filed: 2012-05-15
Fiscal period: fiscal Q1 2012
Accession: 0001104659-12-037472 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All CARDIFF ONCOLOGY, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2012-03-31	1,182,155	USD
At 2011-12-31	1,039,257	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2012-03-31	5,516,157	USD
At 2011-12-31	5,270,525	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit
At 2012-03-31	-4,334,002	USD
At 2011-12-31	-4,231,268	USD
At 2010-12-31	-4,995,365	USD
At 2009-12-31	-3,786,709	USD
At 2008-12-31	-4,047,807	USD
At 2007-12-31	-1,645,793	USD
At 2007-01-31	1,129,659	USD
At 2006-01-31	3,480,710	USD
At 2005-01-31	3,190,935	USD
At 2004-01-31	-1,578,125	USD
At 2003-01-31	-1,195,104	USD
At 2002-01-31	-719,395	USD
At 2001-01-31	-240,359	USD
At 2000-01-31	27,240	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2012-03-31	586,777	USD
At 2011-12-31	700,374	USD
At 2011-03-31	88,522	USD
At 2010-12-31	58,703	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2012-01-01 to 2012-03-31	-1,162,642	USD	91
1999-08-04 to 2012-03-31	-43,204,814	USD	4624
2011-01-01 to 2011-12-31	-2,239,212	USD	365
2011-01-01 to 2011-03-31	-551,987	USD	90
2010-01-01 to 2010-12-31	-5,449,138	USD	365
2009-01-01 to 2009-12-31	-2,483,807	USD	365
2008-01-01 to 2008-12-31	-5,166,240	USD	366
2007-02-01 to 2007-12-31	-4,683,141	USD	334
2006-02-01 to 2007-01-31	-7,134,067	USD	365
2005-02-01 to 2006-01-31	-7,844,326	USD	365
2004-02-01 to 2005-01-31	-5,371,027	USD	366
2003-02-01 to 2004-01-31	-383,021	USD	365
2002-02-01 to 2003-01-31	-481,609	USD	365
2001-02-01 to 2002-01-31	-524,224	USD	365
2000-02-01 to 2001-01-31	-267,599	USD	366
1999-08-04 to 2000-01-31	-14,760	USD	181

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2012-01-01 to 2012-03-31	98,009	USD	91
1999-08-04 to 2012-03-31	342,312	USD	4624
2011-01-01 to 2011-03-31	1,528	USD	90

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2012-03-31	-44,770,633	USD
At 2011-12-31	-43,598,431	USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

Period	Value	Unit	Days
2012-01-01 to 2012-03-31	66,010,076	shares	91
2011-01-01 to 2011-03-31	54,137,893	shares	90

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

Period	Value	Unit	Days
2012-01-01 to 2012-03-31	66,010,076	shares	91
2011-01-01 to 2011-03-31	54,137,893	shares	90

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2012-03-31	114,323	USD
At 2011-12-31	22,504	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2012-01-01 to 2012-03-31	102,830	USD	91
1999-08-04 to 2012-03-31	11,583,155	USD	4624
2011-01-01 to 2011-03-31	64,160	USD	90

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2012-01-01 to 2012-03-31	-1,130,218	USD	91
1999-08-04 to 2012-03-31	-39,858,849	USD	4624
2011-01-01 to 2011-03-31	-719,978	USD	90

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2012-03-31	705,751	USD
At 2011-12-31	842,172	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
1999-08-04 to 2012-03-31	1,325,372	USD	4624
2011-01-01 to 2011-03-31	28,511	USD	90

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2012-03-31	1,532,727	USD
At 2011-12-31	1,429,881	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2012-03-31	946,952	USD
At 2011-12-31	928,364	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2012-03-31	76,533	USD
At 2011-12-31	99,140	USD

Common-stock repurchase payments

Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.

Period	Value	Unit	Days
1999-08-04 to 2012-03-31	500,000	USD	4624

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2012-03-31	67,146,857	shares
At 2011-12-31	64,422,157	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2012-03-31	40,429,821	USD
At 2011-12-31	39,360,625	USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2012-03-31	362,081	USD
At 2011-12-31	174,581	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2012-03-31	585,775	USD
At 2011-12-31	501,517	USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

Period	Value	Unit	Days
At 2012-03-31	42,441	USD
At 2011-12-31	42,658	USD

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

Period	Value	Unit	Days
2012-01-01 to 2012-03-31	-1,172,202	USD	91
1999-08-04 to 2012-03-31	-44,770,633	USD	4624
2011-01-01 to 2011-03-31	-561,547	USD	90

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2012-01-01 to 2012-03-31	826,964	USD	91
1999-08-04 to 2012-03-31	23,367,818	USD	4624
2011-01-01 to 2011-03-31	551,044	USD	90

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

Period	Value	Unit	Days
2012-01-01 to 2012-03-31	6,190	USD	91
1999-08-04 to 2012-03-31	227,989	USD	4624
2011-01-01 to 2011-03-31	2,555	USD	90

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2012-01-01 to 2012-03-31	889,500	USD	91
1999-08-04 to 2012-03-31	18,321,505	USD	4624
2011-01-01 to 2011-03-31	600,000	USD	90

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2012-01-01 to 2012-03-31	-22,607	USD	91
1999-08-04 to 2012-03-31	76,533	USD	4624
2011-01-01 to 2011-03-31	9,093	USD	90

Inspect the source

Entity: CARDIFF ONCOLOGY, INC. / CIK 0001213037
Captured: 2026-09-20T07:45:48.177Z
SEC response SHA-256: 5fefa7380123168da913afadb8db67f9296559e6467fa58ab3879c6c623fb326

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001213037.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))